Skip to main content
SpringerLink
Log in

Clinical and Economic Factors in the Selection of Drugs for Gastroesophageal Reflux Disease

  • Leading Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bate CM, Cost-effectiveness of omeprazole in the treatment of reflux oesophagitis. British Journal of Medical Economics 1: 53–61, 1991

    Google Scholar 

  • Bate CM. Reflux oesophagitis. Martin Dunitz, London, England, 1992

    Google Scholar 

  • Bate CM, Crowe JP, Dickinson RJ, Green JRB, Bannerjee S, et al. Reflux oesophagitis resolves more rapidly with omeprazole 20mg om than with ranitidine 150mg bd; omeprazole 40mg om provides further benefit in unresponsive patients. British Journal of Clinical Research 2: 133–148, 1991

    Google Scholar 

  • Bate CM, Heavey DJ, McCloy R, Wilkinson SP. Gastroesophageal reflux. In Scott C (Ed.) Update Postgraduate Centre Series, Reed Healthcare, 1991

    Google Scholar 

  • Bate CM, Keeling PWN, O’Morain C, Wilkinson SP, Foster DN et al. Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations. Gut 31: 968–972, 1990

    Article  PubMed  CAS  Google Scholar 

  • Bate CM, Richardson PDI. A one year model for the cost-effectiveness of treating reflux oesophagitis. British Journal of Medical Economics 2: 5–11, 1992a

    Google Scholar 

  • Bate CM, Richardson PDI. Symptomatic assessment and cost-effectiveness of treatments for reflux oesophagitis: comparisons of omeprazole and histamine H2 receptor antagonists. British Journal of Medical Economics 2: 37–48, 1992b

    Google Scholar 

  • Bramble MG. Open-access endoscopy — a nationwide survey of current practice. Gut 33: 282–285, 1992

    Article  PubMed  CAS  Google Scholar 

  • Crean G. Causes of dyspepsia and its effective treatment. Prescriber January: 29–37, 1992

    Google Scholar 

  • Eriksen CA, Cuschieri A. Diagnostic tests for gastroesophageal reflux disease. In Hennessy TPJ et al. (Eds) Reflux oesophagitis, Butterworths, London 55–86, 1989

    Google Scholar 

  • Gear MW, Wilkinson SP. Open access upper alimentary endoscopy. British Journal of Hospital Medicine 41: 438–444, 1989

    PubMed  CAS  Google Scholar 

  • Heading RC. Epidemiology of oesophageal reflux disease. Scandinavian Journal of Gastroenterology 24 (Suppl. 168): 33–37, 1989

    Google Scholar 

  • Hillman AL, Bloom BS, Fendrick AM, Schwartz JS. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. Archive of Internal Medicine 152: 1467–1472, 1992

    Article  CAS  Google Scholar 

  • Holt S, Howden CW. Omeprazole overview and opinion. Digestive Diseases and Sciences 36: 385–393, 1991

    Article  PubMed  CAS  Google Scholar 

  • Stacher G, Weiss W. Diagnosis of gastroesophageal reflux disease. Scandinavian Journal of Gastroenterology 24 (Suppl 156): 21–24, 1989

    Article  Google Scholar 

  • Stoker Dl, Williams JG, Leicester RC, Colin-Jones DG. Oesophagitis — a five year review. Gut 29: A1450, 1988

    Google Scholar 

  • Weinbeck M, Berges W. Esophageal disorders in the etiology and pathophysiology of dyspepsia. Scandinavian Journal of Gastroenterology 20 (Suppl. 109): 133–137, 1985

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Royal Albert Edward Infirmary, Wigan Lane, Wigan, Lancashire, WN1 2NN, England

    C. M. Bate

  2. Clinical Research Department, Astra Pharmaceuticals Ltd, Home Park, Kings Langley, Hertfordshire, England

    P. D. I. Richardson

Authors
  1. C. M. Bate
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. D. I. Richardson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bate, C.M., Richardson, P.D.I. Clinical and Economic Factors in the Selection of Drugs for Gastroesophageal Reflux Disease. Pharmacoeconomics 3, 94–99 (1993). https://doi.org/10.2165/00019053-199303020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199303020-00002

Keywords

Search

Navigation